
pmid: 12435808
c-Myc is known to control cell proliferation and apoptosis, and much effort has been focused on elucidating the mechanisms by which c-Myc works. In this study, we show that c-Myc expression is induced by many cellular insults, including cisplatin, doxorubicin, paclitaxel, 5-flourouracil, H(2)O(2), and radiation, and the enhanced expression of c-Myc protects against cell death caused by these cellular insults through ornithine decarboxylase (ODC) induction. To investigate the cellular protective role of c-Myc, we constructed a stable transfectant of ODC, one of the many transcriptional targets of c-Myc in cells, and found that enhanced expression of ODC inhibited cell death induced by cellular insults such as cisplatin, H(2)O(2,) and radiation. We also found that cisplatin activated nuclear factor-kappaB, and this subsequently induced c-Myc expression, resulting in the blocking of apoptosis through ODC induction. The results herein, therefore, strongly suggest another role for c-Myc in a stress-response function; that is, it promotes cell survival under stressful conditions.
Cisplatin/pharmacology, ODC, CDDP, PI, Gene Expression, electrophoretic mobility shift assay, Tumor Cells, Cultured, ornithine decarboxylase, Gy, glyceraldehyde-3-phosphate dehydrogenase, Cell Survival/physiology, reactive oxygen species, propidium iodide, Cultured, GAPDH, NF-kappa B, ROS, cis-diamminedichloroplatinum(II), kilobase pair, Tumor Cells, human dental fibroblast, retinal pigment epithelial, Enzyme Induction, NF- B, 5-flourouracil, RPE, Proto-Oncogene Proteins c-myc/genetics, Antineoplastic Agents/pharmacology, I BDD, 570, Cell Survival, HDF, Ornithine Decarboxylase/biosynthesis*, 610, Antineoplastic Agents, Gene Expression/drug effects, Ornithine Decarboxylase, EMSA, Proto-Oncogene Proteins c-myc, nuclear factor- B, Humans, dominant-negative of I B mutant, Proto-Oncogene Proteins c-myc/physiology*, 5-FU, dominant-negative c-Jun NH2-terminal kinase-1 mutant, gray, kbp, NF-kappa B/metabolism, JNKDD, Cisplatin, Ornithine Decarboxylase/metabolism
Cisplatin/pharmacology, ODC, CDDP, PI, Gene Expression, electrophoretic mobility shift assay, Tumor Cells, Cultured, ornithine decarboxylase, Gy, glyceraldehyde-3-phosphate dehydrogenase, Cell Survival/physiology, reactive oxygen species, propidium iodide, Cultured, GAPDH, NF-kappa B, ROS, cis-diamminedichloroplatinum(II), kilobase pair, Tumor Cells, human dental fibroblast, retinal pigment epithelial, Enzyme Induction, NF- B, 5-flourouracil, RPE, Proto-Oncogene Proteins c-myc/genetics, Antineoplastic Agents/pharmacology, I BDD, 570, Cell Survival, HDF, Ornithine Decarboxylase/biosynthesis*, 610, Antineoplastic Agents, Gene Expression/drug effects, Ornithine Decarboxylase, EMSA, Proto-Oncogene Proteins c-myc, nuclear factor- B, Humans, dominant-negative of I B mutant, Proto-Oncogene Proteins c-myc/physiology*, 5-FU, dominant-negative c-Jun NH2-terminal kinase-1 mutant, gray, kbp, NF-kappa B/metabolism, JNKDD, Cisplatin, Ornithine Decarboxylase/metabolism
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 36 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
